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Abstract
Objective. The objective of this study was to describe the involvement of patients or their representatives in quality management
(QM) functions and to assess associations between levels of involvement and the implementation of patient-centred care strategies.
Design. A cross-sectional, multilevel study design that surveyed quality managers and department heads and data from an organiza-
tional audit.
Setting. Randomly selected hospitals (n= 74) from seven European countries (The Czech Republic, France, Germany, Poland,
Portugal, Spain and Turkey).
Participants.Hospital quality managers (n= 74) and heads of clinical departments (n= 262) in charge of four patient pathways (acute
myocardial infarction, stroke, hip fracture and deliveries) participated in the data collection between May 2011 and February 2012.
Main Outcome Measures. Four items reﬂecting essential patient-centred care strategies based on an on-site hospital visit: (1)
formal survey seeking views of patients and carers, (2) written policies on patients’ rights, (3) patient information literature including
guidelines and (4) fact sheets for post-discharge care. The main predictors were patient involvement in QM at the (i) hospital level
and (ii) pathway level.
Results. Current levels of involving patients and their representatives in QM functions in European hospitals are low at hospital
level (mean score 1.6 on a scale of 0 to 5, SD 0.7), but even lower at departmental level (mean 0.6, SD 0.7). We did not detect asso-
ciations between levels of involving patients and their representatives in QM functions and the implementation of patient-centred
care strategies; however, the smallest hospitals were more likely to have implemented patient-centred care strategies.
Conclusions. There is insufﬁcient evidence that involving patients and their representatives in QM leads to establishing or imple-
menting strategies and procedures that facilitate patient-centred care; however, lack of evidence should not be interpreted as evi-
dence of no effect.
Keywords: quality management, quality measurement, patient-centred care, hospital care, hospital, patient involvement
†Details are present in Appendix 1.
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Background
The role of involving patients in designing and assessing
health care services has increased substantially over the last
few years [1]. Approaches towards user involvement go back
over decades, motivated mainly by ethical and governance con-
cerns [2]. More recently, the patient safety movement has
demonstrated the need to involve patients and learn from their
experiences in order to ensure safe and high quality patient-
centred care [3, 4]. The involvement of patients in designing
and assessing their care is seen as a strategy to promote
patient-centred care, acknowledged as an integral dimension of
health care quality [4, 5]. This is highlighted in various recom-
mendations of the high-proﬁle inquiry into the quality and
safety concerns at Mid-Staffordshire Foundation NHS Trust
that speciﬁcally emphasizes the importance of patient repre-
sentation and the prioritizing of patients’ needs in the organ-
ization and delivery of health care [6].
Patient involvement is referred to under different terms in
the literature, including ‘patient and public involvement’, ‘user
involvement’, ‘lay involvement’ or ‘patient representation’ [7].
We will focus here on the established term patient involvement
to denote the involvement of patients or their representatives
in activities related to planning, designing or assessing quality
management (QM) in hospitals. The involvement of patients
and their representatives in health care takes many forms,
ranging from lay membership in managerial boards to involve-
ment in condition-speciﬁc activities, such as services design,
development of patient information material, identiﬁcation of
improvement priorities, or assessing and interpreting results of
patient surveys. Hospitals recognized for their leadership in
the ﬁeld of patient-centred care involve patients or patient
representatives in formal quality functions (such as setting
standards or targets, and discussing results).
Yet, the evidence base on the involvement of patients and
patient representatives in quality functions is limited. For
example, it has been demonstrated that patient involvement is
frequently limited to the highest organizational level and not
devolved to clinical units [8]. Moreover, it focuses mainly on
the least technical issues of care (e.g. patient education) where
patients can make constructive contributions; however, these
contributions are not necessarily acted on subsequently [9].
Other studies exhibited that patient involvement is often pro-
fessionally led and can be resource intensive and its gains are
hard to identify [10]. One of the few studies to explore the re-
lationship between hospital organizational characteristics and
consumer involvement quantitatively detected only a low and
non-signiﬁcant correlation [11].
Given the dearth of research on the actual involvement of
patients or their representatives in formal QM roles [1, 12]
and the effect of such strategies on organizational policies and
procedures [13], the aims of this study were (i) to describe the
involvement of patients or their representatives in QM at hos-
pital and at department (or pathway) levels and (ii) to investi-
gate the effect of involvement on the implementation of
strategies to improve patient-centredness of care in European
hospitals.
Methods
Study design, setting and population
This study was conducted as part of the ‘Deepening our under-
standing of quality improvement in Europe (DUQuE)’ project,
which was funded by the EU 7th Research Framework
Program [14]. The overall aims and objectives of the project are
described in detail elsewhere [15]. We employed a cross-
sectional, multilevel study design in which patient-level measure-
ments are nested in hospital departments, which are in turn
nested in hospitals in seven EU countries. Hospitals were
randomly selected from the participating countries: Czech
Republic, France, Germany, Poland, Portugal, Spain and Turkey
between May 2011 and January 2012.
Each hospital nominated a coordinator (usually the quality
manager) who attended training sessions on sampling proce-
dures and data collection. Data collection included question-
naires to professionals and patients, chart review, administrative
data and an organizational audit. Full details of the ﬁeld test are
described elsewhere [15]. The data reported in this paper ema-
nates from surveys to the hospital quality manager, heads of
departments and an on-site audit on the implementation of
patient-centred care strategies. For the audit, training sessions
were carried out with independent surveyors in each country.
The selection criteria for these surveyors differed slightly
between country, but a general requirement was independence
of the hospital setting undergoing audit and experience in ac-
creditation visits to assess hospital quality and safety. An IT
platform was created to collect data from electronic surveys
and the organizational audit. Responses rates were high (89%
for professional questionnaires and 99% for the organizational
audit).
Conceptual framework
We used a directed acyclic graph (DAG) to depict our knowl-
edge and assumptions about the relationships under study and
to guide our covariate selection for confounding control in the
statistical analysis [16]. Although this study has a cross-
sectional design, it is still useful to make the assumed and
hypothesized relationships transparent with the visual aid of a
DAG. The DAG in Fig. 1 reﬂects how patient involvement in
QM at hospital and departmental levels can inﬂuence patient-
centred care strategies. Hospital confounders (size, ownership
and teaching status) potentially affect each of these measures.
Outcomes, predictors and covariates
The outcome variable is a score reﬂecting the implementation
of essential patient-centred care strategies at the departmental
level, measured through on-site visit for each of the four
departments. This construct contains the following items: (a) a
formal survey seeking views of patients and carers, (b) written
policies on patients’ rights, (c) patient information literature in-
cluding guidelines and (d) fact sheets for post-discharge care.
Each item is scored on a ﬁve-point scale (no or negligible com-
pliance, low compliance, medium compliance, high-extensive
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compliance and full compliance), with further instructions to
account for the extent of implementation such as whether patient
surveys had been fully documented and reported, whether
patient education material had been designed in a non-technical
language or whether evidence indicated an organization-wide im-
plementation. The outcome measure was assessed by independ-
ent hospital surveyors during an on-site hospital visit. This visit
lasted on average 1.5 days and covered overall hospital organiza-
tion and organizational procedures implemented in the four path-
ways reported here. This outcome measure was developed based
on a review of accreditation and quality standards, policy docu-
ments and the literature and builds on previous research [17]. We
acknowledge that patient-centeredness is a broader construct
than reﬂected by these four items, as discussed in our own re-
search [18, 19]. However, in the context of this study, our primary
interest was to assess the implementation of patient-centred care
strategies as stipulated in relevant policies on hospital QM
systems. These aspects are most frequently covered by the chosen
items.
The key predictor variable is the score on the involvement
of patients and their representatives in QM functions. This
was measured for each hospital once at the hospital level and
then again for each of the four departments. These constructs
are based on a ﬁve-item scale that has been validated and used
in previous research [17]. Items assess whether patients are
involved in (i) the development of quality criteria/standards/
protocols, (ii) the design/organization of processes, (iii) quality
committees, (iv) quality improvement projects and (v) discus-
sion of results of quality improvement projects. Each item is
scored on a four-point scale including the categories never,
sometimes, usually and always. The mean score of these four
items is used in the associational analysis. Covariates include
country and hospital level (size of the hospital, ownership and
teaching status).
Analysis
The main hypothesis is that the involvement of patients and
their representatives at hospital and/or departmental level
is positively associated with essential patient-centred care
strategies. This is based on the assumption that involving
patients in designing and assessing care would lead to imple-
mentation of policies to support patient views, rights and
access to relevant patient information. We ﬁrst present descrip-
tive statistics on characteristics of hospitals participating in the
study, and department-speciﬁc means and SDs for the main
predictors and outcomes in our study. We also describe items
that were aggregated to build the hospital- and department-
level patient involvement and patient information constructs.
Fisher’s exact test or Pearson’s χ2 statistics were used to deter-
mine whether there were signiﬁcant differences in these items
across pathways, as appropriate.
Covariate adjustments in our multilevel models were guided
by the DAG shown in Fig. 1, which we assumed to be represen-
tative of the data-generating mechanism. These models were
restricted to complete observations for the predictor, outcome
and all confounders in the analysis. Two separate sets of models
were used to investigate (i) whether patient involvement in QM
at the ‘hospital’ level was associated with patient-centred care
strategies at the ‘department’ level and (ii) whether patient in-
volvement at the ‘department’ level was associated with patient-
centred care strategies.
We used multivariate linear mixed models with a random
intercept by country to account for clustering of hospitals
within countries and adjusted for hospital size, ownership and
teaching status. Models assessing the association between
department-level patient involvement and patient-centred care
strategies were further adjusted for hospital-level patient in-
volvement, as this variable is a confounder in our DAG. All
statistical analyses were carried out in SAS (version 9.3, SAS
Institute Inc., NC, USA, 2011).
Results
Overall, 74 hospitals contributed data to be included in this
study. The majority were public hospitals (79.7%) and about
half (44.5%) were teaching hospitals. Larger hospitals with
>500 beds accounted for more than half of the hospitals in
the sample. A total of 72 of the 74 hospitals completed the
hospital quality manager and head of department question-
naires (Table 1).
In Table 2, we provide descriptive statistics for predictor
and outcome variables. The score for the predictor variable is
much higher at hospital level, whereas scores for the involve-
ment of patients and their representatives are universally lower
across departments. The score of the outcome variable is
highest for deliveries and lowest for hip fracture care.
Details of the implementation of strategies to involve
patients and their representatives in QM functions are pre-
sented in Table A1. Patients and their representatives are rarely
involved in developing quality criteria, designing/organizing
processes of care, participating in quality committees or dis-
cussing results of quality improvement projects. Somewhat
more frequently, they are involved in the implementation of
quality improvement projects. There was little variation in the
observed involvement across departments. As shown in
Table A2, slightly more than half of the departments fully
Figure 1 Directed acyclic graph for the relationships between
patient involvement in QM at hospital and departmental levels
and patient-centred care strategies.
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complied with having established formal surveys seeking the
views of patients or carers and almost three-quarters had
written policies on patients’ rights in place. Roughly 38 and
43%, respectively, were fully compliant with providing patient
information literature and fact sheets for post-discharge care.
The implementation of these strategies differed across path-
ways for the latter two items, with child delivery care yielding
higher responses for patient information (P= 0.054) and AMI
care yielding higher responses for the implementation of post-
discharge care (P= 0.033).
Results from our multilevel models show that there is insuf-
ﬁcient evidence of an association between the involvement of
patients and their representatives in QM functions at hospital
level and the implementation of patient-centred care strategies
in any of the four departments. We did not detect a relation-
ship between patient-centred care strategies and type of hos-
pital or hospital size (Table 3).
A similar analysis was conducted to assess the relationship
between departmental-level strategies for the involvement of
patients and their representatives in QM function and the
implementation of patient-centred care strategies. Again, our
evidence did not support a relationship between either patient
involvement or hospital-type and patient-centred care strat-
egies in any of the pathways. However, we found that the smal-
lest hospitals were more likely to implement patient-centred
care strategies than larger hospitals (Table 4). This effect was
observed for all pathways, with the exception of stroke care.
Discussion
We aimed to describe the involvement of patients in QM at
hospital and at department level and to investigate the effect
of levels of involvement on organizational policies and proce-
dures to improve patient-centred care strategies in European
hospitals.
Levels of implementation of patient involvement
and patient-centred care strategies
Despite years of advocacy and policy support, the actual in-
volvement of patients and their representatives in QM func-
tions remains low in our study, in particular with regard to
important domains such as establishing quality standards or
organizing processes, for which evidence suggests that patients
can make important contributions [20, 21]. The only domain
where patients and their representatives appear to be involved
to some extent is regarding the implementation of quality im-
provement projects. This ﬁnding is consistent and observed
both at hospital and departmental level. At departmental level,
patient involvement is less frequent than at hospital level, and
there is little variation across patient pathways. This is sup-
ported by comparable studies suggesting that ‘beyond board
level, involvement of users, patients […] and the general
public is patchy and superﬁcial.’ [8]. Given that the ratings on
the level of patient involvement are based on self-reports by
managers; the actual level of involvement may be even lower in
practice. Patient-centred care strategies are implemented some-
what more heterogeneously, with pathways for deliveries yield-
ing higher scores, although these differences do not reach
statistical signiﬁcance. The observed levels of implementation
of key strategies to elicit and understand patient views and
provide crucial information to patients are low. Among the
four assessed pathways, the deliveries and acute myocardial in-
farction pathways report higher levels of implementation of
patient-centred care strategies.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Characteristics of hospitals participating in study
Characteristic N %
All Hospitals 74 100
Czech Republic 12 16.2
France 11 14.8
Germany 4 5.4
Poland 12 16.2
Portugal 11 14.8
Spain 12 16.2
Turkey 12 16.2
Teaching hospitals 33 44.5
Public hospitals 59 79.7
Approximate number of beds in hospital
<200 7 9.4
200–500 22 29.7
501–1000 31 41.8
>1000 14 18.9
Completed hospital quality manager
questionnaires
72 97.3
Competed head of department questionnaires 72 97.3
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Descriptive statistics for patient involvement at hospital and departmental levels and patient-centred care strategies
All conditions AMI Deliveries Hip fracture Stroke
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Predictors
Patient involvement in QM at ‘hospital’ level (0–5) 1.6 (0.7)
Patient involvement in QM at ‘departmental’ level (0–5) 0.6 (0.7) 0.8 (0.7) 0.6 (0.8) 0.6 (0.6) 0.6 (0.7)
Outcome
Patient-centred care strategies (0–4) 2.8 (0.9) 2.8 (0.9) 3.0 (0.9) 2.6 (0.9) 2.8 (0.9)
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. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Results of multivariable analysis for relationship of patient involvement in QM at the hospital level and patient-centred care strategiesa
Patient-centred care strategies
AMI (N = 69) Deliveries (N = 69) Hip Fracture (N = 71) Stroke (N = 71)
b SE pr>|t| b SE pr >|t| b SE pr >|t| b SE pr >|t|
Patients involved in
QM at hospital level
0.19 0.15 0.211 0.06 0.14 0.667 0.04 0.15 0.784 0.17 0.15 0.253
Teaching hospital
Yes −0.08 0.29 0.793 −0.05 0.28 0.847 0.00 0.28 0.996 0.26 0.28 0.354
No (reference) (reference) (reference) (reference)
Public hospital
Yes 0.19 0.31 0.539 0.08 0.29 0.779 0.11 0.29 0.696 0.13 0.29 0.643
No (reference) (reference) (reference) (reference)
Hospital size
<200 (reference) (reference) (reference) (reference)
200–500 −0.38 0.41 0.359 −0.69 0.42 0.106 −0.20 0.41 0.631 −0.63 0.41 0.127
501–1000 0.10 0.42 0.808 −0.26 0.43 0.550 0.00 0.42 0.995 −0.23 0.41 0.583
>1000 0.15 0.47 0.757 −0.08 0.48 0.876 −0.39 0.47 0.415 −0.32 0.47 0.502
aMultivariate linear mixed models with a random intercept by country to account for clustering of hospitals within countries and adjusted for hospital size, ownership and teaching status.
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Table 4 Results of multivariate analysis of the relationship between patient involvement in QM at the department level and patient-centred care strategiesa
Patient-centred care strategies
AMI (N = 48) Deliveries (N = 58) Hip fracture (N = 57) Stroke (N = 64)
b SE pr >|t| b SE pr >|t| b SE pr >|t| b SE pr >|t|
Patients involved in QM at
departmental level
0.29 0.18 0.112 0.03 0.13 0.833 0.21 0.19 0.277 −0.14 0.18 0.452
Patients involved in QM
at hospital level
0.15 0.14 0.299 0.12 0.15 0.427 0.02 0.16 0.913 0.18 0.15 0.250
Teaching hospital
Yes −0.36 0.32 0.267 0.09 0.23 0.706 −0.22 0.33 0.524 0.15 0.30 0.630
No (reference) (reference) (reference) (reference)
Public hospital
Yes 0.15 0.33 0.646 −0.01 0.27 0.972 0.03 0.30 0.922 0.30 0.33 0.367
No (reference) (reference) (reference) (reference)
Hospital size
<200 (reference) (reference) (reference) (reference)
200–500 −1.77 0.52 0.002 −0.82 0.38 0.038 −1.25 0.61 0.047 −0.48 0.47 0.320
501–1000 −1.16 0.52 0.031 −0.38 0.37 0.317 −1.12 0.62 0.081 −0.06 0.48 0.900
>1000 −1.05 0.55 0.062 0.05 0.43 0.910 −1.30 0.64 0.049 −0.15 0.52 0.781
aMultivariate linear mixed models with a random intercept by country to account for clustering of hospitals within countries and adjusted for hospital size, ownership, teaching status, and ‘Patients
involved in QM at hospital level’.
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Associations between patient involvement
and patient-centred care strategies
We hypothesized that higher involvement of patient and
patient representative involvement would be associated with
efforts to understand patient’s views by conducting formal
surveys, establishing written policies on patient’s rights, produ-
cing and providing patient information literature on the care
pathway, and providing facts sheets for post-discharge care.
We were not able to detect any signiﬁcant association between
levels of patient involvement and implementation of patient-
centred care strategies. This might be interpreted in various
ways. First, it is possible that we did not detect an association
because hospitals had involved patients and their representatives
only recently and sufﬁcient time has not passed for their involve-
ment to lead to establishing or implementing policies or proce-
dures. Secondly, patient involvement may have some positive
and measurable effects; however, they do not affect the policies
and procedures investigated here. For example, Mockford et al.
demonstrated that patient and public involvement has a range of
impacts on health care services, in particular around information
development and dissemination, including patient information
brochures [1]. However, previous research studies have not dir-
ectly assessed the relationship we examined in this study.
Thirdly, involving patients and their representatives in QM func-
tions might have no measurable effect on the policies and proce-
dures investigated here. It is conceivable that some hospitals
strive for patient involvement without providing the resources
or commitment to translate this into changes in service organ-
ization or delivery. In individual cases, a hospital might perform
‘lip service’, rather than a service transformation function, as
reported elsewhere [9]. This might be a particular issue if
patients and their representatives are not properly selected or
mentored to make a contribution. Recent research conﬁrms this
hypothesis and suggests that for patient involvement to be ef-
fective, facilitators who can ‘support, engage, navigate and advo-
cate’ for participation and inﬂuence are needed [22]. While
examples from leading advocates of patient-centred care, such
as the Dana Faber Institute and the Children’s Hospital in
Boston in the USA, provide evidence that patients make valu-
able contributions to QM work, the success of patient involve-
ment may depend largely on being able to recruit patients with
the right experience and their ability to express their views con-
structively [23]. The only effect observed in multivariate analysis
was one of hospital size, where we detected an inverse relation-
ship between levels of involvement of patients and their repre-
sentatives in QM and the implementation of patient-centred
care strategies. This might be explained by smaller hospitals
being more community oriented than large teaching hospitals
[24]. However, we did not detect a clear size gradient; thus, there
might be other factors in the group of the smallest hospitals that
explain higher implementation.
Limitations
Our study has a number of limitations. Some of the common
limitations of the DUQuE study are referred to elsewhere [15].
Speciﬁc limitations of this study are the lack to control for
temporality, i.e. the duration or history of involving patients or
their representatives in QM functions, as it might be assumed
that it takes some time from ﬁrst involving patients and their
representatives to establishing relevant policies and proce-
dures. An added complexity is that seven countries participat-
ing in the study might be at different stages on their journey to
patient involvement. Ideally, it would have been desirable to
highlight these rather than to adjust for the country effect in
the multivariable analysis; however, the study was not designed
to allow this. Another limitation is that we were not able to use
information collected from hospital board members on the
criteria for selection and training of patients and their repre-
sentatives. This would have allowed illumination of the impact
of these criteria on levels of involvement and strength of asso-
ciation with patient-centred care strategies. However, as
described by Secanell et al., the response rate to this particular
questionnaire was poor [15]. The involvement of patients itself
in designing this research would have been very desirable,
ideally as a mixed-methods study, however, this was infeasible
given the complexity of the project, timescales, multiple set-
tings in multiple countries and resources available [18].
Another limitation is that we were not able to assess the
factors that motivated hospitals to involve patients and their
representatives in QM functions. Knowledge of these factors
might inform further research on the impact of involving
patients and their representatives in hospital QM functions. A
ﬁnal limitation is that in this study we were not able to assess
the ability of the involved patients to exert inﬂuence on the
decision-making process regarding the organization of hos-
pital services. This is an issue that has been addressed in previ-
ous studies, suggesting that levels of patient involvement that
could be characterized as tokenism might be measurable with
the scales used here but would not reﬂect the professionally
led agenda for change and thus confound the relationship
between involvement and outcomes [9, 10, 22, 25]. Given
these limitations, the failure to detect statistically signiﬁcant
associations between patient involvement and the implementa-
tion of strategies to improve patient-centeredness of care
should not deﬂect from the general beneﬁts of patient involve-
ment [12] and should not be interpreted as evidence of no
relationship.
Conclusion
Current levels of involving patients and their representatives
in QM functions in European hospitals are low overall. It is
slightly higher regarding hospital-wide activities as compared to
departmental-speciﬁc functions and more frequent regarding
speciﬁc projects than broader functions of planning and asses-
sing results. We did not detect a relationship between levels of
involving patients and their representatives in QM functions and
the implementation of patient-centred care strategies. Further re-
search should address the motivations and contextual factors
for patient involvement in QM in greater detail. Currently, there
is insufﬁcient evidence to conclude that involving patients
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and their representatives lead to establishing or implementing
policies and procedures that facilitate patient-centred care;
however, this lack of evidence should not be interpreted as evi-
dence of no effect.
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Table A1 Patient involvement in planning for quality at hospital and departmental levels
Patients are involved in Hospital quality
manager
Head of pathway P-value*
AMI Deliveries Hip fracture Stroke
N % N % N % N % N %
Total respondents,N (row %) 72 100 64 24.4 65 24.8 65 24.8 68 25.9
Development of quality criteria
Never 42 56.7 22 34.3 37 56.9 31 47.6 38 55.8 0.211
Sometimes 20 27.0) 28 43.7 17 26.1 19 29.2 21 30.8
Usually 8 10.8 4 6.2 4 6.1 8 12.3 7 10.2
Always 2 2.7 4 6.2 6 9.2 3 4.6 2 2.9
Missing 0 0 6 9.3 1 1.5 4 6.1
Design/organization of processes
Never 45 60.8 28 43.7 43 66.1 36 55.3 41 60.2 0.217
Sometimes 21 28.3 24 37.5 11 16.9 17 26.1 18 26.4
Usually 3 4.0 5 7.8 6 9.2 8 12.3 8 11.7
Always 2 2.7 2 3.1 4 6.1 1 1.5 1 1.4
Missing 1 1.3 5 7.8 1 1.5 3 4.6
Quality committees
Never 48 64.8 30 46.8 37 56.9 44 67.6 41 60.2 0.276
Sometimes 13 17.5 16 25.0 16 24.6 10 15.3 15 22.0
Usually 4 5.4 7 10.9 3 4.6 2 3.0 8 11.7
Always 7 9.4 3 4.6 6 9.2 6 9.2 3 4.4
Missing 0 0 8 12.5 3 4.6 3 4.6 1 1.4
Quality improvement projects
Never 37 50.0 23 35.9 37 56.9 35 53.8 35 51.4 0.202
Sometimes 20 27.0 23 35.9 16 24.6 19 29.2 20 29.4
Usually 9 12.1 9 14.0 4 6.1 3 4.6 9 13.2
Always 6 8.1 1 1.5 5 7.6 4 6.1 3 4.4
Missing 0 0 8 12.5 3 4.6 4 6.1 1 1.4
Discussion of quality improvement project results
Never 44 59.4 25 39.0 39 60.0 37 56.9 36 52.9 0.322
Sometimes 16 21.6 18 28.1 14 21.5 18 27.6 20 29.4
Usually 5 6.7 10 15.6 4 6.1 5 7.6 10 14.7
Always 7 9.4 1 1.5 4 6.1 2 3.0 1 1.4
Missing 0 0 10 15.6 4 6.1 3 4.6 1 1.4
*P-value for differences in items across pathways from Fisher’s exact test.
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Table A2 Patient-centred care strategies in four departments
Patient-centred care strategies All conditions AMI Deliveries Hip fracture Stroke P-value
N % N % N % N % N %
TotalN (row %) 295 100 74 25.0 73 24.7 74 25.0 74 25.0
Formal survey seeking views of patients and carers
No or negligible compliance 43 14.5 12 16.2 9 12.3 11 14.8 11 14.8 0.952*
Low compliance 21 7.1 8 10.8 3 4.1 5 6.7 5 6.7
Medium compliance 38 12.8 9 12.1 9 12.3 11 14.8 9 12.1
High, extensive compliance 25 8.4 5 6.7 6 8.2 5 6.7 9 12.1
Full compliance 165 55.9 38 51.3 45 61.6 42 56.7 40 54.0
Missing 3 1.0 2 2.7 1 1.3
Written policies on patients’ rights
No or negligible compliance 14 4.7 4 5.4 2 2.7 4 5.4 4 5.4 0.969*
Low compliance 12 4.0 2 2.7 2 2.7 5 6.7 3 4.0
Medium compliance 33 11.1 10 13.5 6 8.2 9 12.1 8 10.8
High, extensive compliance 23 7.7 5 6.7 5 6.8 6 8.1 7 9.4
Full compliance 210 71.1 51 68.9 57 78.0 50 67.5 52 70.2
Missing 3 1.0 2 2.7 1 1.3
Patient information literature includes guidelines
No or negligible compliance 70 23.7 14 18.9 11 15.0 24 32.4 21 28.3 0.054**
Low compliance 32 10.8 10 13.5 5 6.8 8 10.8 9 12.1
Medium compliance 40 13.5 13 17.5 7 9.5 14 18.9 6 8.1
High, extensive compliance 39 13.2 8 10.8 14 19.1 5 6.7 12 16.2
Full compliance 111 37.6 27 36.4 35 47.9 23 31.0 26 35.1
Missing 3 1.0 2 2.7 1 1.3
Fact sheets for post-discharge care
No or negligible compliance 46 15.5 7 9.4 20 27.3 11 14.8 8 10.8 0.033**
Low compliance 29 9.8 6 8.1 3 4.1 9 12.1 11 14.8
Medium compliance 29 9.8 7 9.4 4 5.4 12 16.2 6 8.1
High, extensive compliance 60 20.3 19 25.6 16 21.9 13 17.5 12 16.2
Full compliance 128 43.3 33 44.5 29 39.7 29 39.1 37 50.0
Missing 3 1.0 2 2.7 1 1.3
*P-value for differences in items across pathways from Fisher’s exact test.
**P-value for differences in items across pathways from χ2 test.
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